HIV / AIDS in the News

HIV report highlights ‘stark contrast’ in access to PrEP among different ethnicities - The Pharmaceutical Journal

 

Study suggests CBD could help block HIV transmission - greenstate.com

 

High cost of compassion threatens to shutter Christian home for people with HIV in Winnipeg - Broadview Magazine

 

IDVYNSO: A New Chapter in HIV Care - Black Health Matters

 

GILD: Oncology, cell therapy, inflammation, and HIV portfolios advance with new data and innovation - TradingView

 

Beyond awareness: How youth leadership is reshaping the HIV response - HIVPlusMag.com

 

When Unilateral Leg Swelling Is Not Deep Vein Thrombosis: A Case of Disseminated Kaposi Sarcoma Revealing Advanced Human Immunodeficiency Virus - Cureus

 

HIV Vaccine Awareness Day and NMAC’s New Factsheet - poz.com

 

Global HIV Trends and Vaccine Breakthroughs - Straits Research

 

Struggling with daily HIV meds? Monthly shots may be the answer - HIVPlusMag.com

 

Semaglutide slows epigenetic aging in a randomized trial of HIV-associated lipohypertrophy - Nature

 

Barcelona Institute for Global Health: Expanded TB screening does not speed up treatment initiation or improve survival in hospitalised patients with HIV - European AIDS Treatment Group

 

Bears stadium fight, HIV funding and alder sues the feds | The Chicago Report - FOX 32 Chicago

 

London School of Hygiene & Tropical Medicine: Ending undernutrition could stop nearly a quarter of TB cases - European AIDS Treatment Group

 

CIDRAP: TB costs in poor countries exceed those of HIV, estimates suggest - European AIDS Treatment Group

 

Grant funding cut for HIV/AIDS care in Chicago | The Chicago Report - FOX 32 Chicago

 

New JIAS viewpoint for International Day Against Homophobia, Biphobia and Transphobia - European AIDS Treatment Group

 

HIV i-Base: England’s HIV Action Plan: on target for HIV 2030 goals on preventable deaths but not for diagnoses: some key populations not included - European AIDS Treatment Group

 

HIV i-Base: New study predicts that PrEP efficacy in men is driven by drug levels in cells: matching earlier results in women - European AIDS Treatment Group

 

[Publications] CHAI: Lenacapavir and long-acting HIV PrEP: flash market update and spotlights across early adopters - European AIDS Treatment Group

 

SB 1023 takes aim at the invisible insurance barriers to HIV prevention - Los Angeles Blade

 

IAVI: HIV Vaccine Awareness Day 2026: African research leading the charge - European AIDS Treatment Group

 

New JIAS viewpoint for HIV Vaccine Awareness Day - European AIDS Treatment Group

 

Adolescents' knowledge of legal capacity to independently consent linked to higher STI/HIV testing - Medical Xpress

 

A Symbolic HIV Funeral Protest - poz.com

 

2026 HIV Oscar Party Gets “Messy” - poz.com

 

Dancing in the Dark - poz.com

 

Everyday–June 2026 - poz.com

 

Twice-Yearly HIV Treatment on the Horizon - poz.com

 

Guiding Right expands HIV testing and prevention services in Oklahoma - The Journal Record